Neville Rodie & Shaw’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
21,415
-27,980
-57% -$2.63M 0.1% 109
2026
Q1
$5.84M Sell
49,395
-17,710
-26% -$2.19M 0.42% 53
2025
Q4
$8.44M Sell
67,105
-24,029
-26% -$3.13M 0.6% 43
2025
Q3
$13.3M Sell
91,134
-25,149
-22% -$3.8M 0.96% 28
2025
Q2
$18.1M Sell
116,283
-6,470
-5% -$1.03M 1.35% 20
2025
Q1
$20.2M Sell
122,753
-3,634
-3% -$604K 1.58% 17
2024
Q4
$20.6M Sell
126,387
-2,107
-2% -$377K 1.5% 17
2024
Q3
$25.1M Sell
128,494
-3,772
-3% -$695K 1.85% 15
2024
Q2
$22.9M Sell
132,266
-5,313
-4% -$884K 1.74% 15
2024
Q1
$23.3M Buy
137,579
+2,910
+2% +$545K 1.78% 15
2023
Q4
$26.6M Sell
134,669
-1,457
-1% -$258K 2.17% 9
2023
Q3
$23.7M Sell
136,126
-843
-0.6% -$153K 2.11% 9
2023
Q2
$23.6M Buy
136,969
+1,233
+0.9% +$213K 2.03% 10
2023
Q1
$22.6M Buy
135,736
+2,288
+2% +$375K 2.05% 8
2022
Q4
$19.6M Sell
133,448
-2,446
-2% -$362K 1.84% 13
2022
Q3
$20.2M Sell
135,894
-760
-0.6% -$127K 1.98% 8
2022
Q2
$23.5M Sell
136,654
-461
-0.3% -$79.7K 2.1% 7
2022
Q1
$26.2M Sell
137,115
-2,322
-2% -$459K 1.95% 8
2021
Q4
$34M Sell
139,437
-2,289
-2% -$501K 2.41% 7
2021
Q3
$27.5M Sell
141,726
-2,233
-2% -$451K 2.14% 8
2021
Q2
$26.8M Sell
143,959
-701
-0.5% -$122K 2.07% 8
2021
Q1
$22.8M Sell
144,660
-2,932
-2% -$465K 1.89% 9
2020
Q4
$24.4M Sell
147,592
-7,299
-5% -$1.19M 2.12% 8
2020
Q3
$25.6M Buy
154,891
+1,307
+0.9% +$201K 2.42% 6
2020
Q2
$21M Buy
153,584
+1,133
+0.7% +$148K 2.17% 8
2020
Q1
$17.9M Sell
152,451
-958
-0.6% -$126K 2.18% 11
2019
Q4
$20.3M Buy
153,409
+6,360
+4% +$790K 1.99% 12
2019
Q3
$18.3M Sell
147,049
-2,856
-2% -$345K 1.94% 12
2019
Q2
$17M Sell
149,905
-3,143
-2% -$329K 1.8% 12
2019
Q1
$15.4M Buy
153,048
+2,278
+2% +$207K 1.63% 15
2018
Q4
$12.9M Sell
150,770
-2,223
-1% -$200K 1.56% 16
2018
Q3
$14M Sell
152,993
-1,494
-1% -$133K 1.38% 18
2018
Q2
$13.2M Buy
154,487
+2,153
+1% +$182K 1.39% 19
2018
Q1
$12.7M Sell
152,334
-2,572
-2% -$203K 1.4% 18
2017
Q4
$11.2M Buy
154,906
+12,387
+9% +$851K 1.18% 27
2017
Q3
$9.09M Buy
142,519
+1,953
+1% +$122K 1.01% 32
2017
Q2
$8.77M Buy
140,566
+7,661
+6% +$452K 1% 32
2017
Q1
$7.09M Buy
+132,905
New +$7.18M 0.81% 38

Other funds holding ZTS

Neville Rodie & Shaw's ZTS Position: Q2 2026 in Review

Neville Rodie & Shaw reduced its Zoetis (ZTS) stake by 57% in Q2 2026, selling an estimated $2.63M and leaving 21,415 shares worth $1.54M. The position accounts for 0.1% of the portfolio, ranked #109.

Neville Rodie & Shaw first reported a position in ZTS in Q1 2017 and has held it in 38 quarters since. The position peaked at $34M in Q4 2021. 480 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Neville Rodie & Shaw held 21,415 shares of Zoetis worth $1.54M as of Q2 2026.
  • Neville Rodie & Shaw sold 27,980 Zoetis shares in Q2 2026, an estimated $2.63M.
  • Zoetis made up 0.1% of Neville Rodie & Shaw's portfolio in Q2 2026, its #109 holding.
  • Neville Rodie & Shaw first reported a position in Zoetis in Q1 2017 and has held it in 38 quarters since.
  • Neville Rodie & Shaw's Zoetis position peaked at $34M in Q4 2021.
  • 480 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.